
Vericel Corporation VCEL
$ 36.53
-0.04%
Quarterly report 2025-Q3
added 11-06-2025
Vericel Corporation Operating Cycle 2011-2025 | VCEL
Annual Operating Cycle Vericel Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 177 | 183 | 191 | 167 | 172 | 166 | 135 | 150 | 160 | 96.9 | 144 | - | 487 | 182 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 487 | 96.9 | 185 |
Quarterly Operating Cycle Vericel Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 173 | 178 | 195 | - | 162 | 166 | 173 | - | 159 | 160 | 193 | - | 97.9 | 85.5 | 188 | - | 176 | 154 | 161 | 69.6 | 185 | 256 | 188 | 74.5 | 163 | 181 | 171 | 68.3 | 95.2 | 113 | 106 | 71.4 | 117 | 98.3 | 172 | 94.4 | 143 | 122 | 90.6 | 64.6 | 88.1 | 73.3 | 80.4 | 50.8 | 77.4 | 169 | - | - | - | 122 | 160 | 88.8 | 411 | 456 | 456 | - | 91.2 | 91.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 456 | 50.8 | 150 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.89 | 3.82 % | $ 812 M | ||
|
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.22 | -1.08 % | $ 249 M | ||
|
Aptevo Therapeutics
APVO
|
191 | $ 1.07 | -5.31 % | $ 295 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
195 | $ 26.35 | 4.25 % | $ 1.28 B | ||
|
Anika Therapeutics
ANIK
|
325 | $ 9.62 | 0.63 % | $ 141 M | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 13.28 | -5.78 % | $ 874 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
116 | $ 550.6 | -2.43 % | $ 41.7 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
360 | $ 2.37 | 3.04 % | $ 14.9 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 91.34 | 1.68 % | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
86.5 | $ 27.0 | -1.85 % | $ 1.74 M | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
408 | $ 11.3 | -2.04 % | $ 731 M | ||
|
Biogen
BIIB
|
452 | $ 175.09 | 0.57 % | $ 25.5 B | ||
|
Abeona Therapeutics
ABEO
|
387 | $ 5.07 | -5.5 % | $ 108 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
364 | $ 87.9 | -0.1 % | $ 9.07 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
137 | $ 24.31 | 2.92 % | $ 2.88 B | ||
|
ADiTx Therapeutics
ADTX
|
841 | $ 1.6 | -28.57 % | $ 21.1 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
349 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M |